Future Therapies in PAH: Update on the New Landscape and Drugs in the Pipeline

Advances in Pulmonary Hypertension

Preston, I Future Therapies in PAH: Update on the New Landscape and Drugs in the Pipeline Advances in Pulmonary Hypertension.¹ 

关键词: Cardiology;    Pulmonology;    Psychosocial Issues;    Lifestyle Issues;    WHO Group 1- Pulmonary Arterial Hypertension;    WHO Group 4;    PH Medications;    Potential Therapies;    symptoms;    Research;    Neonatal;    Exercise;    nutrition;    Cardiopulmonary rehabilitation;    Genetics;    Chronic thromboembolic pulmonary hypertension;    Oral therapy;    IV therapy;    Subcutaneous therapy;    Inhaled therapy;    Phosphodiesterase Inhibitors (PDE-5 Inhibitors);    Prostacyclin;    Endothelin Receptor Antagonists;    nitric oxide;    Anticoagulation;    Diuretics;    exercise hemodynamic testing;    6-Minute Walk Test;    thromboendarterectomy;    vasculogenesis;    vascular remodeling;    intermedial hypertrophy;    Preserved ejection fraction;    endothelial dysfunction;    Endothelin;    Endothelial progenitor cells;    Functional Class;    Pregnancy;    patient-reported outcomes;    Drug development;    clinical trial;    clinical trial endpoints;    biomarkers;    REVEAL;    Animal Models of PH;    pre-clinical research;    Classification;    Epidemiology;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

 

【 授权许可】

All Rights reserved